Pralsetinib
Pralsetinib, sold under the brand name Gavreto, is a medication approved RET mutation-positive medullary thyroid cancer and RET fusion-positive differentiated thyroid cancer refractory to radioactive iodine therapy. Reference standards of Pralsetinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Pralsetinib
[catalogue_number] => PA 16 3770000
[category_ids] => ,82,78,70,69,76,
[chemical_name] =>
[weight] => 533.61
[form] => C27H32FN9O2
[cas] => 2097132-94-8
[pslug] => 2097132-94-8-pralsetinib-api-pa163770000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 16 3770000
Molecular Formula : C27H32FN9O2
Molecular Weight : 533.61
stdClass Object
(
[pname] => (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine Hydrochloride
[catalogue_number] => PA 16 3771000
[category_ids] => ,82,78,70,69,76,
[chemical_name] =>
[weight] => 242.68
[form] => C10H12ClFN4
[cas] => 2097133-17-8
[pslug] => 2097133-17-8-s-1-6-4-fluoro-1h-pyrazol-1-yl-pyridin-3-yl-ethan-1-amine-hydrochloride-pa163771000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine Hydrochloride
Catalogue No.:PA 16 3771000
Molecular Formula : C10H12ClFN4
Molecular Weight : 242.68
stdClass Object
(
[pname] => Methyl cis-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylate
[catalogue_number] => PA 16 3771001
[category_ids] => ,82,78,70,69,76,
[chemical_name] =>
[weight] => 359.43
[form] => C18H25N5O3
[cas] => 2778223-51-9
[pslug] => 2778223-51-9-methyl cis-1-methoxy-4-4-methyl-6-5-methyl-1h-pyrazol-3-yl-amino-2-pyrimidinyl-cyclohexanecarboxylate-pa163771001
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Methyl cis-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylate
Catalogue No.:PA 16 3771001
Molecular Formula : C18H25N5O3
Molecular Weight : 359.43
stdClass Object
(
[pname] => cis-1-Methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylic Acid
[catalogue_number] => PA 16 3771002
[category_ids] => ,82,78,70,69,76,
[chemical_name] =>
[weight] => 345.4
[form] => C17H23N5O3
[cas] => 2778223-52-0
[pslug] => 2778223-52-0-cis-1-methoxy-4-4-methyl-6-5-methyl-1h-pyrazol-3-yl-amino-2-pyrimidinyl-cyclohexanecarboxylic-acid-pa163771002
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
cis-1-Methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxylic Acid
